NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fibralign Corporation

Fibralign Corporation

Private
Union City, CaliforniaHealthcare & Life Scienceshttps://www.fibralignbio.com/

Last Round

Grant

Jan 22, 2019

Total Funding Raised

$4.12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Fibralign Corporation is a medical device company that develops and produces therapeutic biomedical devices for regenerative medicine using its proprietary Nanoweave® technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical deviceregenerative medicinecollagen scaffoldsoft tissue repairlymphedema treatmentbiomaterialsimplantable devicesurgical scaffoldbiotechtissue engineeringmedtechreconstructive surgerybiocompatible materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fibralign Corporation Comparables

Compare Fibralign Corporation with similar companies based on industry and business-model similarity.

Fibralign Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lympha Motus
81%
Nanofiber Solutions, LLC
81%
GeniPhys
76%

Fibralign Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 22, 2019
AngelNov 28, 2017
GrantSep 1, 2017
GrantJun 20, 2014

Key People

Founding team and executive leadership

Michael Paukshto

Founder and CTO

Founding Team

Greg King

President CEO

Executive Team

Fibralign Corporation Investors

Notable investors and investment history

Fibralign Corporation investors
InvestorRounds
National Cancer InstituteGrant
AngelMDAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 34% month-over-month.

  • Jan 22, 2019

    Raised $997K in grant funding.

Fibralign Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fibralign Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fibralign Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnion City, California
Employee Range12
Year Founded2007
Last FundingJan 22, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.